Hing C. Wong, Ph.D. 13D and 13G filings for HCW Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-13 4:30 pm Purchase |
2025-05-15 | 13D | HCW Biologics Inc. HCWB |
Hing C. Wong, Ph.D. | 501,911 23.380% |
501,911 (New Position) |
Filing |